Federated Hermes, Inc. Biote Corp. Transaction History
Federated Hermes, Inc.
- $43 Billion
- Q4 2024
A detailed history of Federated Hermes, Inc. transactions in Biote Corp. stock. As of the latest transaction made, Federated Hermes, Inc. holds 786 shares of BTMD stock, worth $2,664. This represents 0.0% of its overall portfolio holdings.
Number of Shares
786
Previous 1,143
31.23%
Holding current value
$2,664
Previous $6,000
33.33%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding BTMD
# of Institutions
90Shares Held
18.5MCall Options Held
0Put Options Held
0-
325 Capital LLC New York, NY4.55MShares$15.4 Million12.7% of portfolio
-
Bandera Partners LLC New York, NY2.44MShares$8.26 Million5.9% of portfolio
-
Black Rock Inc. New York, NY1.61MShares$5.44 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.43MShares$4.85 Million0.0% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT1.35MShares$4.58 Million0.04% of portfolio
About biote Corp.
- Ticker BTMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Care Facilities
- Shares Outstandng 7,574,270
- Market Cap $25.7M
- Description
- biote Corp. operates in medical practice-building business within the hormone optimization space. The company offers a platform for Biote-certified practitioners to optimize imbalances in their patient's hormone, vitamin, and mineral levels, as well as prescribe bioidentical hormone therapies and recommend dietary supplements. It also sells Biot...